257K
Downloads
197
Episodes
The Cardiovascular CME podcast is a new educational offering from Mayo Clinic, featuring content geared towards physicians, physician assistants, and nurse practitioners who are interested in exploring a multitude of cardiology-related topics. Tune in and subscribe to explore today’s most pressing cardiology topics with your colleagues at Mayo Clinic and gain valuable insights that can be directly applied to your practice. No CME credit offered for podcast episodes at this time.
Episodes
Monday May 24, 2021
What is New Managing Lipids?
Monday May 24, 2021
Monday May 24, 2021
Recent Developments in the Field of Lipid Management
Guest: Stephen L. Kopecky, M.D. (@DrSteveKopecky)
Host: Thomas G. Allison, Ph.D., M.P.H. (@DrTAllison)
Statins and lifestyle changes are still the first line choices for the management of low-density lipoprotein (LDL) cholesterol to reduce the risk of heart disease. Recent developments in the field of lipid management, however, provide promising treatment options for patients who are statin intolerant or simply not achieving their LDL goals, or have elevated levels of triglycerides or lipoprotein(a), also called LP(a).
Joining us today to discuss recent developments in the field of lipid management is Stephen L. Kopecky, M.D., a preventive cardiologist here at Mayo Clinic in Rochester, Minnesota.
Specific topics discussed:
- The end of the statin era?
- New treatment options for patients who are statin intolerant
- Triglycerides: fibrates and statins — and fish oil
- LP(a) as a risk marker in patients with atherosclerotic cardiovascular disease or familial hyperlipidemia
- Use of proprotein convertase subtilisin/kexin type 9 serine protease (PCSK9) inhibitors
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.
No CME credit offered for this episode.
Podcast transcript can be found here.